Previous Close | 8.25 |
Open | 8.31 |
Bid | 7.75 x 800 |
Ask | 8.51 x 1800 |
Day's Range | 7.68 - 8.32 |
52 Week Range | 7.61 - 19.00 |
Volume | |
Avg. Volume | 572,372 |
Market Cap | 642.873M |
Beta (5Y Monthly) | 1.12 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.65 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 16.00 |
Insight into Paragon 28's First Quarter Financial Performance and Future Outlook
Q1 2024 Paragon 28 Inc Earnings Call
ENGLEWOOD, Colo., May 08, 2024--Paragon 28, Inc. (NYSE: FNA) ("Paragon 28" or "Company"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today reported financial results for the quarter ended March 31, 2024, and reaffirmed its 2024 net revenue guidance.